Stephane Schubhan, one of six men hospitalized after the clinical trial, still suffers from neurological damage. Jean-Francois Monier/AFP/Getty Images hide caption

toggle caption Jean-Francois Monier/AFP/Getty Images

Opana pills, seen in 2010, before Endo Pharmaceuticals changed the formula in a move intended to deter abuse. Tom Walker/Flickr hide caption

toggle caption Tom Walker/Flickr
How A Painkiller Designed To Deter Abuse Helped Spark An HIV Outbreak
  • Download
  • <iframe src="https://www.npr.org/player/embed/472538272/472716178" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

"Everyone that's in there right now has probably done it," Clyde Polly says about Opana injections at his home. Seth Herald for NPR hide caption

toggle caption Seth Herald for NPR
Inside A Small Brick House At The Heart Of Indiana's Opioid Crisis
  • Download
  • <iframe src="https://www.npr.org/player/embed/469525114/472553161" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Harvoni can cure hepatitis C, but the drug costs a fortune. Are loans to patients the answer? Lloyd Fox/Baltimore Sun/TNS via Getty Images hide caption

toggle caption Lloyd Fox/Baltimore Sun/TNS via Getty Images

Valeant Pharmaceuticals has been the focus of a congressional investigation into high drug prices. . Michael Nagle/Bloomberg via Getty Images hide caption

toggle caption Michael Nagle/Bloomberg via Getty Images
Katie Park/NPR
Cancer And Arthritis Drugs Drive Up Spending On Medicines
  • Download
  • <iframe src="https://www.npr.org/player/embed/470417680/470486343" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Erbitux is used to treat cancers that start in the head and neck and tumors there that spread from other parts of the body. Because its effectiveness varies, should the price also? Dr. P. Marazzi/Science Source hide caption

toggle caption Dr. P. Marazzi/Science Source

Multiple sclerosis pill Tecfidera is on the top 10 list of most costly specialty drugs, as measured by overall spending, for California's health benefit system for public workers and retirees. John/Flickr hide caption

toggle caption John/Flickr

Martin Shkreli was CEO of Turing Pharmaceuticals when the company boosted the price of a drug by 5,000 percent. He has since resigned. Paul Taggart/Bloomberg via Getty Images hide caption

toggle caption Paul Taggart/Bloomberg via Getty Images

A 12-week regimen of Harvoni is 90 percent effective in curing an infection with hepatitis C, doctors say. It also costs about $95,000. Baltimore Sun/TNS via Getty Images hide caption

toggle caption Baltimore Sun/TNS via Getty Images
States Deny Pricey Hepatitis C Drugs To Most Medicaid Patients
  • Download
  • <iframe src="https://www.npr.org/player/embed/460086615/461206268" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A recent analysis by the Kaiser Family Foundation finds that Medicare recipients taking Revlimid for cancer could end up paying, on average, $11,538 out of pocket for the drug in 2016, even if the medicine is covered by their Medicare Part D plan. Carmine Galasso/MCT/Landov hide caption

toggle caption Carmine Galasso/MCT/Landov

Breast cancer drug Herceptin is one of the medicines that are typically covered by insurers but often at a high out-of-pocket cost for patients. Jeff J Mitchell/Getty Images hide caption

toggle caption Jeff J Mitchell/Getty Images
Diane Bigda/Getty Images/Illustration Works
Menopause: A Gold Mine For Marketers, Fewer Payoffs For Women
  • Download
  • <iframe src="https://www.npr.org/player/embed/455039878/455367763" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Maryland pharmacist Narender Dhallan often has to decide whether to fill a prescription and lose money or send a customer to another store. Cindy Carpien for NPR hide caption

toggle caption Cindy Carpien for NPR
How Generic Drugs Can Cost Small Pharmacies Big Bucks
  • Download
  • <iframe src="https://www.npr.org/player/embed/450600567/450937911" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript